PTC Therapeutics Inc (NAS:PTCT)
$ 44.225 -0.395 (-0.89%) Market Cap: 3.41 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

PTC Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 10, 2020 / 06:00PM GMT
Release Date Price: $49.8 (+0.14%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the PTC Therapeutics, Inc. Annual Meeting. At this time, I would like to turn the conference over to Dr. Stuart Peltz. Sir, please begin.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Thank you. Good morning. Good morning, folks. Welcome to the -- will the meeting please come to order? As you heard, I'm Stuart Peltz, I'm the Chief Executive Officer of PTC Therapeutics, and I'd like to welcome you to our Virtual 2020 Annual Meeting of Stockholders.

With us today are members of our Board of Directors and our senior management. Aside from myself, the Board is represented by Michael Schmertzler, Allan Jacobson, Stephanie Okey, Emma Reeve, Glenn Steele, David Southwell, Dawn Svoronos and Jerry Zeldis. Michael Schmertzler, the Chairperson of the Board of Directors, will preside over today's meeting.

The meeting agenda, along with the meeting protocol, are included under the section of our annual meeting web portal labeled Meeting Material.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot